Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$204.84 USD
+1.25 (0.61%)
Updated May 9, 2024 04:00 PM ET
After-Market: $204.85 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$204.84 USD
+1.25 (0.61%)
Updated May 9, 2024 04:00 PM ET
After-Market: $204.85 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Zacks News
eHealth (EHTH) Q4 Earnings Top, Approved Members Fall Y/Y
by Zacks Equity Research
eHealth (EHTH) Q4 results reflect lower operating costs and expenses. However, revenues declined and so did approved members.
The Zacks Analyst Blog Highlights Apple, Linde, Marsh & McLennan Companies, GSK and Expedia
by Zacks Equity Research
Apple, Linde, Marsh & McLennan Companies, GSK and Expedia are included in this Analyst Blog.
Top Analyst Reports for Apple, Linde & Marsh & McLennan
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Linde plc (LIN) and Marsh & McLennan Companies, Inc. (MMC).
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Factors That Make Marsh & McLennan (MMC) Stock A Lucrative Bet
by Zacks Equity Research
Marsh & McLennan (MMC) remains well-poised for growth on the back of solid contributions from business units. Strong cash-generating abilities is another tailwind for the stock.
Marsh & McLennan (MMC) Q4 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results reflect sound contributions from the Consulting segment and well-performing international operations, partly offset by escalating operating costs.
Marsh & McLennan (MMC) Q4 Earnings Top Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 5% and 4.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q4 Earnings on Jan 26: AJG, MMC and WRB
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to aid fourth-quarter results of insurers like AJG, MMC and WRB. However, an active catastrophe environment is likely to have weighed on insurers' performance.
Why Marsh & McLennan (MMC) Might Surprise This Earnings Season
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Marsh & McLennan (MMC) Sustain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect solid segmental performances, partly offset by elevated compensation and benefits expenses.
The Zacks Analyst Blog Highlights Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson
by Zacks Equity Research
Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson are part of the Zacks top Analyst Blog.
What's in Store for Arthur J. Gallagher (AJG) in Q4 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results are expected to reflect new business, strong retention and renewal premium increases across its business lines.
Top Stock Reports for Exxon Mobil, Fomento Economico Mexicano & Prologis
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), Fomento Econmico Mexicano, S.A.B. de C.V. (FMX) and Prologis, Inc. (PLD).
5 Insurance Stocks Likely to Zoom Past Q4 Earnings Estimates
by Kaibalya Pravo Dey
Increasing interest rates, growing awareness, the scaling of businesses and other factors are likely to have supported the fourth-quarter performances of insurers like Marsh & McLennan, American International, Aflac, Everest Re and Voya Financial.
Why Marsh & McLennan (MMC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Marsh & McLennan (MMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher (AJG) Expands in Ireland With Buyout
by Zacks Equity Research
The buyout of First Ireland Risk will help Arthur J. Gallagher & Co.'s (AJG) expand its footprint in Ireland.
The Zacks Analyst Blog Highlights Aflac, Reinsurance Group of America, Marsh & McLennan Companies, Unum Group and The Travelers Companies
by Zacks Equity Research
Aflac, Reinsurance Group of America, Marsh & McLennan Companies, Unum Group and The Travelers Companies are part of the Zacks top analyst blog.
5 Insurance Stocks to Buy Ahead of Q4 Earnings Results
by Nalak Das
Five insurance companies are set to beat on fourth-quarter earnings. These are: AFL, RGA, MMC, UNM and TRV.
Arthur J. Gallagher (AJG) Aids Health Insurance Market With JCB
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of JCB is likely to strengthen its student health insurance market expertise and fortify its presence on the West Coast.
Marsh & McLennan (MMC) Unit Buys HMS Insurance in Maryland
by Zacks Equity Research
Marsh & McLennan's (MMC) business, Marsh, can gain significantly from the HMS Insurance acquisition through its subsidiary, MMA.
Arthur J. Gallagher (AJG) Buys NEK Insurance, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of NEK Insurance is likely to support cross-selling opportunities.
Arthur J. Gallagher (AJG) Expands in Australia With Buyout
by Zacks Equity Research
The buyout of Aviation Insurance Australia is set to help Arthur J. Gallagher & Co. (AJG) expand its footprint in Australia.
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson and Brown & Brown
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson and Brown & Brown have been highlighted in this Industry Outlook article.
5 Insurance Brokers to Watch Amid Industry Headwinds
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, AJG, WLTW and BRO.